OBJECTIVE:
To assess the clinical impact of copy neutral changes detected by single-nucleotide polymorphism (SNP) microarray analysis during prenatal diagnosis. STUDY DESIGN: A retrospective review was performed on amniotic fluid specimens from one prenatal diagnosis center and patients with copy neutral changes were identified on SNP microarray analysis. Clinical impacts including further testing options and patient decisions were evaluated. RESULTS: Twelve cases with isolated copy neutral changes were identified among a total of 443 amniotic fluid specimens (2.7%) sent for SNP microarray analysis. There were four cases with an increased number of short contiguous runs of regions of homozygosity (ROH) associated with an isolated population, two cases of long ROH in chromosomes 7 and 14 suggesting possible uniparental disomy (UPD), and six cases with long stretches of ROH in multiple chromosomes indicating identity by descent. Four of the cases had further analysis performed through an online ROH analysis tool in an attempt to identify recessive genes in the ROH region that were associated with specific ultrasound findings seen in the fetuses and positive results were seen in two cases. Two genes associated with cleft lip were identified in one case and one gene associated with clubfeet was found in the other case. In both cases, further genetic testing options were offered and the patients declined to proceed. UPD was ruled out in the case with possible UPD 14 and the patient declined UPD testing on the case with a possible UPD 7. After being informed of the microarray results and the significance of the ROH findings, all patients opted to continue with the pregnancy except one, who terminated due to severe abnormal ultrasounds findings and poor prognosis of the fetus. Of the pregnancies continued, one patient had a fetal demise at 22 weeks and another patient was induced at 29 weeks due to holoprosencephaly. CONCLUSION: Copy neutral changes were seen in 2.7% of patients in our study. The identification of these changes provided more testing options for the patients and helped patients make better informed decisions. Due to the complexity of these findings, genetic counseling is important. Detection of copy neutral changes did not seem to change pregnancy decisions in our small patient population. Maternal-Fetal Medicine, University of Illinois at Chicago., Chicago, IL OBJECTIVE: Prenatal aneuploidy testing requires complex counseling as recommended by ACOG. Decision making is complicated and little is known about patients' understanding of prenatal aneuploidy testing. This pilot study sought to investigate patients' knowledge and understanding of this testing. STUDY DESIGN: A self-directed survey was offered to pregnant women between 20-40 weeks gestational age (GA) at the University of Illinois at Chicago. The 21 question survey focused on knowledge and understanding of aneuploidy testing, testing options, how subjects chose their test, and results they received. Survey data were then compared with information extracted from medical records regarding each subject's aneuploidy testing type and result.
Qualitative analysis was done on SPSS using descriptive statistics and bivariate analysis. RESULTS: From October 2017 to February 2018, 67 eligible women participated in the survey. Only 41 subjects (62%) accurately knew the results of their aneuploidy testing, 30(44.7%) recalled being told testing was optional, and 51 (76%) did not correctly remember the type of test they had. Abnormal test results did not improve recall; only 1 of the 6 subjects (16%) with abnormal tests accurately recalled their results. Twenty-five subjects (37%) said they chose the type of testing and only 21 (31%) recalled being told the testing was optional. Level of education did not affect recall. Subjects with high school (HS) degree or less were and those with higher degrees were similar in knowing their test results (10 of 21, 48% vs 31 of 46, 69%, p ¼ .97). Women with HS degree or less were less likely to correctly answer knowledge questions about screening tests (8 of 21, 38%% vs 29 of 46, 63%, p ¼.012). MFM clinic patients had the highest accurate recall of their results (23 of 32, 70%). Ethnicity, age and gestational age were not associated with accuracy in test result recall. CONCLUSION: Despite current professional recommendations which stress the importance of counseling and consent for prenatal aneuploidy testing, our results show pregnant women have poor recollection of this counseling, including the test they chose and the correct result. These findings suggest patients need better counseling and guidance through the antenatal aneuploidy testing process.
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